{"id":"tp-44682","type":"article-newspaper","title":"AbbVie Raises Full-Year Guidance as Non-GAAP EPS Beats Estimates","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/44682","datePublished":"2026-10-30T12:46:56.000Z","dateModified":"2026-10-30T12:46:56.000Z","language":"en","abstract":"Third-quarter revenue reached $17.4 billion, up 10.3% year over year, while the immunology portfolio generated $9.165 billion in global net revenue.","section":"Business","references":[]}